Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

Treatment of INS-1 pancreatic b-cells with poly(ADP-ribose) polymerase (PARP) inhibitors attenuates glucose-induced changes in insulin and lipogenic gene expression

L. Olson, K. Linning, D. Jump, D. Ye

Med Sci Monit 2003; 9(1): 51- :: ID: 15114

Abstract

Chronic hyperglycemia can alter pancreatic b-cell phenotype by decreasing expression of b-cell specific genes including insulin and GLUT2, while increasing expression of metabolic genes normally not abundantly expressed such as l-pyruvate kinase (l-PK), fatty acid synthase (FAS), acetyl-CoA carboxylase, and lactate dehydrogenase. Treatment of INS-1 pancreatic b-cells with high glucose (16.7 mM) for 48 hrs markedly suppressed insulin promoter activity [1] and induced l-PK promoter activity [1,2]. High glucose also elevated intracellular NAD levels 2-fold compared to control. PARP, an enzyme that uses NAD to poly(ADP-ribosy)late nuclear proteins [3], has been suggested to be involved in ß-cell cytotoxicity, regeneration and differentiation [2,4], and adipocyte differentiation [5]. Thus, we examined the ability of PARP inhibitors – nicotinamide (NAM), 3-aminobenzamide (3-AB), and PD128763 (PD) – to attenuate glucose-mediated changes in insulin and lipogenic gene expression and promoter activities in INS-1 cells. Incubation of INS-1 cells in high glucose for 48 hrs suppressed in suppressed insulin mRNA level >80% and induced l-PK, FAS, and SREBP-1c mRNA levels 4.4-, 12.6-, and 2.7-fold, respectively. Treatment with high glucose concentrations also repressed insulin (–327/+30) promoter activity >80%, and induced l-PK (–4.3 kb/+12) and FAS (–2.4 kb/+16) promoter activity 24- and 21-fold, respectively. Treatment of cells with high glucose plus 10 mM NAM, 10 mM 3-AB, or 500 KM PD, increased insulin mRNA levels and promoter activity 3.4- and 10-fold, respectively. PARP inhibitors also attenuated glucose-mediated induction of l-PK, FAS, and SREBP-1c mRNA levels by 55%, 69%, and 45%, respectively. Moreover, PARP inhibitors attenuated the ability of high glucose to activate l-PK and FAS promoters by 51% and 61%, respectively. These results indicate that PARP inhibitors can attenuate adverse changes in gene expression that occur when b-cells are exposed to elevated glucose concentrations.References: 1.Olson LK, Qian J, Poitout V: Mol Endocrinol, 1998; 12(2): 207-219 2.Newburg E, Qian J, Towle HC, Olson LK: Mol Cell Biochem, 2000; 210: 13-21 3.Virag L, Szabo C: Pharmacol Rev, 2002; 54(3): 375-429 4.Okamoto H, Takasawa S: Diabetes, 2002; 51(suppl. 3): S462-S473 5.Smulson ME, Kang VH, Ntambi JM et al: J Biol Chem, 1995; 270(1): 119-127

Keywords: PARP inhibitors, b-cell phenotype, islet of langerhans, Glucose, insulin gene, lipogenic genes

Comments

Editorial

01 May 2022 : Editorial  

Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.937048

Med Sci Monit 2022; 28:e937048

SARS-CoV-2/COVID-19

24 May 2022 : Clinical Research  

Screening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November...

Med Sci Monit In Press; DOI: 10.12659/MSM.936962  

04 May 2022 : Clinical Research  

Effects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...

Med Sci Monit In Press; DOI: 10.12659/MSM.936069  

27 May 2022 : Clinical Research  

Factors Associated with Falls During Hospitalization for Coronavirus Disease 2019 (COVID-19)

Med Sci Monit 2022; 28:e936547

In Press

27 May 2022 : Clinical Research  

Prognostic Significance of Preoperative Integrated Liver Inflammatory Score in Patients with Hepatocellular...

Med Sci Monit In Press; DOI: 10.12659/MSM.937005  

25 May 2022 : Review article  

Narrative Review of the Mechanism of Hip Prosthesis Dislocation and Methods to Reduce the Risk of Dislocation

Med Sci Monit In Press; DOI: 10.12659/MSM.935665  

24 May 2022 : Clinical Research  

Remimazolam Tosilate Sedation with Adjuvant Sufentanil in Chinese Patients with Liver Cirrhosis Undergoing ...

Med Sci Monit In Press; DOI: 10.12659/MSM.936580  

24 May 2022 : Clinical Research  

Screening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November...

Med Sci Monit In Press; DOI: 10.12659/MSM.936962  

Most Viewed Current Articles

30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Nov 2020 : Review article  

Long-Term Respiratory and Neurological Sequelae of COVID-19

DOI :10.12659/MSM.928996

Med Sci Monit 2020; 26:e928996

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750